Yamini V Virkud1, Christoph P Hornik2, Daniel K Benjamin3, Matthew M Laughon4, Reese H Clark5, Rachel G Greenberg2, P Brian Smith6. 1. Massachusetts General Hospital for Children, Boston, MA. 2. Duke Clinical Research Institute, Duke University, Durham, NC. 3. Clemson University, Clemson, SC. 4. University of North Carolina, Chapel Hill, NC. 5. Pediatrix Medical Group, Sunrise, FL. 6. Duke Clinical Research Institute, Duke University, Durham, NC. Electronic address: brian.smith@duke.edu.
Abstract
OBJECTIVE: To assess how neonatal intensive care units followed the American Academy of Pediatrics guidelines for use of dexamethasone in preterm infants by evaluating respiratory support at the time of dexamethasone administration. STUDY DESIGN: This is an observational study of infants discharged from one of 290 neonatal intensive care units from 2003 to 2010. The cohort included very low birth weight (<1500 g birth weight) infants born at ≤32 weeks gestational age. The main outcome was respiratory support at time of exposure to dexamethasone. Significant respiratory support was defined as invasive respiratory support (conventional or high-frequency ventilation) with a fraction of inspired oxygen (FiO2) > 0.3. RESULTS: Of 81 292 infants; 7093 (9%) received dexamethasone. At the time that dexamethasone was initiated, 4604 (65%) of infants were on significant respiratory support. CONCLUSIONS: In accordance with the American Academy of Pediatrics recommendations, a majority of infants were on significant respiratory support when receiving dexamethasone, yet a substantial number of infants still received dexamethasone on less than significant respiratory support. Further research on reducing dexamethasone use in premature infants is required to decrease the risk of neurodevelopmental impairment.
OBJECTIVE: To assess how neonatal intensive care units followed the American Academy of Pediatrics guidelines for use of dexamethasone in preterm infants by evaluating respiratory support at the time of dexamethasone administration. STUDY DESIGN: This is an observational study of infants discharged from one of 290 neonatal intensive care units from 2003 to 2010. The cohort included very low birth weight (<1500 g birth weight) infants born at ≤32 weeks gestational age. The main outcome was respiratory support at time of exposure to dexamethasone. Significant respiratory support was defined as invasive respiratory support (conventional or high-frequency ventilation) with a fraction of inspired oxygen (FiO2) > 0.3. RESULTS: Of 81 292 infants; 7093 (9%) received dexamethasone. At the time that dexamethasone was initiated, 4604 (65%) of infants were on significant respiratory support. CONCLUSIONS: In accordance with the American Academy of Pediatrics recommendations, a majority of infants were on significant respiratory support when receiving dexamethasone, yet a substantial number of infants still received dexamethasone on less than significant respiratory support. Further research on reducing dexamethasone use in premature infants is required to decrease the risk of neurodevelopmental impairment.
Authors: A R Stark; W A Carlo; J E Tyson; L A Papile; L L Wright; S Shankaran; E F Donovan; W Oh; C R Bauer; S Saha; W K Poole; B J Stoll Journal: N Engl J Med Date: 2001-01-11 Impact factor: 91.245
Authors: T M O'Shea; J M Kothadia; K L Klinepeter; D J Goldstein; B G Jackson; R G Weaver; R G Dillard Journal: Pediatrics Date: 1999-07 Impact factor: 7.124
Authors: Barbara Schmidt; Elizabeth V Asztalos; Robin S Roberts; Charlene M T Robertson; Reginald S Sauve; Michael F Whitfield Journal: JAMA Date: 2003-03-05 Impact factor: 56.272
Authors: Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh Journal: Am J Respir Crit Care Med Date: 2011-03-04 Impact factor: 21.405
Authors: Wes Onland; Filip Cools; Andre Kroon; Karin Rademaker; Maruschka P Merkus; Peter H Dijk; Henrica L van Straaten; Arjan B Te Pas; Thilo Mohns; Els Bruneel; Arno F van Heijst; Boris W Kramer; Anne Debeer; Inge Zonnenberg; Yoann Marechal; Henry Blom; Katleen Plaskie; Martin Offringa; Anton H van Kaam Journal: JAMA Date: 2019-01-29 Impact factor: 56.272
Authors: Irina Prelipcean; James Lawrence Wynn; Lindsay Thompson; David James Burchfield; Laurence James-Woodley; Philip B Chase; Christopher P Barnes; Angelina Bernier Journal: Arch Dis Child Fetal Neonatal Ed Date: 2021-02-04 Impact factor: 5.747
Authors: Justin B Josephsen; Brianna M Hemmann; Connie D Anderson; Brett M Hemmann; Paula M Buchanan; Howard L Williams; Lisa M Lubsch; Noah H Hillman Journal: J Perinatol Date: 2021-11-01 Impact factor: 2.521